Showing posts with label Designer babies. Show all posts
Showing posts with label Designer babies. Show all posts

Pros and Cons

Pros
Reduces risk of genetic diseases
Reduces risk of inherited medical conditions
Keep pace with others doing it
Better chance the child will succeed in life
Better understanding of genetics
Increased life span
Can give a child genes that the parents do not carry
Prevent next generation of family from getting characteristics/diseases
Cons
Termination of embryos
Could create a gap in society
Possibility of damage to the gene pool
Baby has no choice in the matter
Genes often have more than one use
Geneticists are not perfect
Loss of Individuality
Other children in family could be affected by parent's decision
Only the rich can afford it

Choice....

Comfortably seated in the fertility clinic with Vivaldi playing softly in the background, you and your partner are brought coffee and a folder. Inside the folder is an embryo menu. Each embryo has a description, something like this:

Embryo 78 – male

• No serious early onset diseases, but a carrier for phenylketonuria (a metabolic malfunction that can cause behavioural and mental disorders. Carriers just have one copy of the gene, so don’t get the condition themselves).
• Higher than average risk of type 2 diabetes and colon cancer.
• Lower than average risk of asthma and autism.
• Dark eyes, light brown hair, male pattern baldness.
• 40% chance of coming in the top half in SAT tests.
There are 200 of these embryos to choose from, all made by in vitro fertilisation (IVF) from you and your partner’s eggs and sperm. So, over to you. Which will you choose?

Deaf lesbians....

With the completion of the human genome project, the genetic basis of disease is becoming better understood. Genetic tests for disabilities are increasingly becoming available to allow couples with a family history of genetic disease to select healthy offspring. But some couples wish to select for disability. Might there be good reasons for acceding to such requests?
A deaf lesbian couple in the United States have deliberately created a deaf child. Sharon Duchesneau and Candy McCullough used their own sperm donor, a deaf friend with five generations of deafness in his family. Like others in the deaf community, Duchesneau and McCullough don't see deafness as a disability. They see being deaf as defining their cultural identity and see signing as a sophisticated, unique form of communication.– (See box ​boxB1B1 for references on commentaries relating to this case.)

Brave new world....




A BRAVE NEW WORLD OF DESIGNER BABIES

The end of sex?

Stanford University professor Henry Greely says that within 20-40 years, hopeful mothers will be able to choose from a plethora of embryos that they can have inserted into the womb.
Advances in medical science have shown that scientists can take the skin cells of mice and turn them into eggs, without them being harvested from the womb.
In humans, the skin cells could be turned into dozens of eggs, and each of them would be decoded and analysed allowing scientists to look for genetic predispositions, both for disease and personal traits.
The best egg would then be fertilised by the sperm and placed on the woman.

By 2038....

Most infants will be ‘designer babies’ in as little as 20 years, a professor claims.Within 20-to-40 years, hopeful mothers will be able to choose the embryos implanted into their wombs based on their preferences for sex, intelligence, musical ability or disease risk, according to Professor Henry Greely from Standard University, who works in bioethics.
Professor Greely, who wrote “The End of Sex and the Future of Human Reproduction”, said: “The majority of babies of people who have good health coverage will be conceived this way.”A designer baby is an embryo that is genetically engineered for specifically selected traits before being implanted into a woman via In Vitro Fertilisation (IVF).Although initially a sci-fi concept, pre-implantation genetic diagnosis already routinely determines if embryos are at risk of diseases such as cystic fibrosis in the United Kingdom (UK) and United States (US). Designer babies are illegal in the UK.
While The Council on Ethical and Judicial Affairs supports genetic selection if it benefits a child’s wellbeing, critics argue choosing ‘preferred’ traits that do not boost health is unethical.Supporters of the practice argue parents can already influence their child’s tastes via lifestyle choices, such as taking them to concerts, and should therefore have the right to “prenatal autonomy”.

HK and biotech boom

Dennis Lo Yuk-ming, 54, is one of Hong Kong’s foremost innovators in the realm of medical science. He was educated at Oxford University, the director of the Li Ka-shing Institute of Health Sciences and professor of medicine at Chinese University. He made a breakthrough discovery in DNA testing of pregnant women 30 years ago that led to the development of non-invasive testing for Down’s syndrome in the fetus. His discovery has benefited millions of women each year but raised an ethical dilemma about designer babies and DNA tests in our everyday lives. Lo, a winner of the Future Science Prize, considered the Chinese equivalent of the Nobel Prize, says the conditions are ripe for a biotech boom in the city.

Can society handle designer babies?

With the advent of genetic engineering technology like CRISPR, the topic of designer babies has come back with a vengeance, along with all the bioethical quandaries: Should parents be able to shape their child's mental and physical traits before they're even born? Will non-engineered children take on social stigma? Will only the rich be able to save their children from a predisposition to diseases like diabetes or brain cancer?

Well, here's another troubling question: What if you could create 80 potential kids, peer into their DNA profile, and choose which one to keep based on its genetic makeup?

In 20 years.....

Most infants will be 'designer babies' in as little as 20 years, a professor claims.
Within 20-to-40 years, hopeful mothers will be able to chose the embryos implanted into their wombs based on their preferences for sex, intelligence, musical ability or disease risk, according to Professor Henry Greely from Standard University, who works in bioethics.
Professor Greely, who wrote 'The End of Sex and the Future of Human Reproduction', said: 'The majority of babies of people who have good health coverage will be conceived this way.'
A designer baby is an embryo that is genetically engineered for specifically selected traits before being implanted into a woman via IVF.
Although initially a sci-fi concept, preimplantation genetic diagnosis already routinely determines if embroyos are at risk of diseases such as cystic fibrosis in the UK and US. Designer babies are illegal in the UK.
While The Council on Ethical and Judicial Affairs supports genetic selection if it benefits a child's wellbeing, critics argue choosing 'preferred' traits that do not boost health is unethical.

Read more

Dawn of the designer baby?

How to strike the right balance in talking about the latest experiment in which a gene in a human embryo was edited? Should it be considered the first step on the road to tailored personal genomes, or a useful advance in what might one day be a valuable medical technique? Or just an incremental step in basic science?
This sort of editing of a genome would have been impossible before the advent in 2012-13 of the CRISPR-Cas9 technique, which uses a set of molecular machinery—basically a bacterial DNA-cleaving enzyme—to modify genes on DNA in a precisely targeted manner. So the result is certainly exciting. And because gene editing in human embryos has profound ethical as well as medical implications, it is controversial. Yet at the same time, the potential of doing such work was already apparent from previous experience with CRISPR, and we know very little at this stage about the implications of such a genetic change for the further development of the embryo. No one is talking yet about doing this in clinical medicine or human reproduction. So the furore over “designer babies,” while predictable, is out of proportion to what has been scientifically achieved here.
The new work was carried out by a team in the US, China and South Korea. It is not the first time that CRISPR has been used to genetically modify a human embryo—that was done in 2015 by researchers in China (see this piece)—but the involvement of teams within the more stringent regulatory and ethical regime of the US marks a significant step in acceptance of such experiments. The 2015 Chinese work was rejected by the two major science journals Nature and Science on ethical grounds, so it is notable that Nature has published the new paper. Nonetheless, it was only because the work had private funding in the US (where the main laboratory was at the Oregon Health and Science University in Portland) that it could sidestep government restrictions.
The researchers used IVF techniques to produce embryos from the sperm of a man carrying a mutant form of a gene called MYBPC3, which causes a rare and severe heart disease called hypertrophic cardiomyopathy (HCM). (Because, like most carriers, the man also had the healthy form of the gene—we have two copies of our genes, one inherited from each parent—he does not suffer from the often fatal condition, but is a carrier.)

Inequality on a biological scale

Imagine you’re having a child in the near future, and with the vast trove of gene-editing technologies that have surfaced, your doctors present a surprising proposition — they promise to customize hair, skin, and eye color, as well as eliminate any pathology, illness, or hereditary affliction that may infirm your baby. Moreover, and more controversially, they inquire if you wish to get rid of vision problems, obesity, mental disorders, or even hair loss. As you can discern, these realities thus present a fairly disquieting dilemma –is there an ethical duty behind using genetic modification to ensure a child’s success, or does such behavior engender a world in which imperfections are substandard, and inequality among humans becomes almost inherent and biological?
The concept of tuning gene-expression and manipulating base pairs has been around for a few years, and in January of 2013, the Zhang Lab published the first method to edit the genome of mouse and human cells using CRISPR, the revolutionary process making waves around the world. More specifically, CRISPR comes in two separate parts – an enzyme called Cas9 that cuts DNA, and a guiding RNA sequence that tells Cas9 where to do so. Something to keep in mind is that there are nearly 6 billion base pairs that make up the human genome, so the guide RNA can sometimes mislead Cas9 to sites that are a base or two off from the intended sequence. This can result in certain genes being modified when doing so was never the intention, but further developments in the tool are gradually preventing this reality.
Most recently, researchers in China have used CRISPR to repair mutations in human embryos that can cause heart disorders, and their work has incited much ethical controversy. Many think that gene editing in plants or mice is less unnatural than in humans, and while I believe such thinking is an insouciant dismissal of the natural world, I understand the concern – the impact of such science becomes tangible when it can affect your children or loved ones. Moreover, using CRISPR in humans is exclusively done through in-vitro fertilization; IVF is a precipitously expensive procedure, one that contrives a striking narrative in which the rich can ensure the biological superiority of their offspring, and the poor are put through the ringer. This doesn’t just mean that financially burdened families can’t choose the eye or skin color of their quickly arriving new-born — their difficulties preclude the elimination of genetic disease or illness. Clearly, the unsettling reality that pervades such technologies is evident when viewed within an often tell-all socioeconomic framework. To think that someone can be denied of CRISPR’s benefit because of an insurance policy or out-of-pocket premium is an unacceptable possibility — and one that deserves to challenged with truculent conviction.

The Designer Baby Era is not upon us

One week ago, MIT Technology Review reported that scientists at an Oregon-based lab had modified the DNA of human embryos using the gene-editing technique known as CRISPR. That was a first for the United States; until then, such a procedure had only ever been done in China.
The researchers, led by Shoukhrat Mitalipov from Oregon Health and Science University, had altered the gene behind an unspecified inherited disease in a number of one-cell embryos. These embryos weren’t allowed to develop for more than a few days, and there was never any intention to implant them into a womb. The story fueled another cycle of discussion about designer babies, and fears that a Gattaca-style world was just around the corner.
But the full details of the experiment, which are released today, show that the study is scientifically important but much less of a social inflection point than has been suggested. “This has been widely reported as the dawn of the era of the designer baby, making it probably the fifth or sixth time people have reported that dawn,” says Alta Charo, an expert on law and bioethics at the University of Wisconsin-Madison. “And it’s not.”
Given the persistent confusion around CRISPR and its implications, I've laid out exactly what the team did, and what it means.

Who did the experiments?

Shoukhrat Mitalipov is a Kazakhstani-born cell biologist with a history of breakthroughs—and controversy—in the stem cell field. He was the scientist to clone monkeys. He was the first to create human embryos by cloning adult cells—a move that could provide patients with an easy supply of personalized stem cells. He also pioneered a technique for creating embryos with genetic material from three biological parents, as a way of preventing a group of debilitating inherited diseases.
Although MIT Tech Review name-checked Mitalipov alone, the paper splits credit for the research between five collaborating teams—four based in the United States, and one in South Korea.

What did they actually do?

The project effectively began with an elevator conversation between Mitalipov and his colleague Sanjiv Kaul. Mitalipov explained that he wanted to use CRISPR to correct a disease-causing gene in human embryos, and was trying to figure out which disease to focus on. Kaul, a cardiologist, told him about hypertrophic cardiomyopathy (HCM)—an inherited heart disease that’s commonly caused by mutations in a gene called MYBPC3. HCM is surprisingly common, affecting 1 in 500 adults. Many of them lead normal lives, but in some, the walls of their hearts can thicken and suddenly fail. For that reason, HCM is the commonest cause of sudden death in athletes. “There really is no treatment,” says Kaul. “A number of drugs are being evaluated but they are all experimental,” and they merely treat the symptoms. The team wanted to prevent HCM entirely by removing the underlying mutation.

Read more

Baby genes for sale?

Designer babies are coming in 20 to 30 years. Your children will be able to select, to some degree, their own children’s hair color, eye color, and, possibly their intelligence. How can we make sure that everyone benefits from these capabilities, rather than reserving them for those with more cash?
The affordable and effective CRISPR technique for modifying DNA has made genetic manipulation akin to cutting and pasting characters in a Microsoft Word document. Equally important, the cost of gene sequencing is dropping fast. It is presently below $1,000 for a human genome to be sequenced and should fall below $100 over the next few years.
With cheaper gene sequencing, the cost of researching genetic traits will plummet. Parents will also be to more accurately analyze the pluses and minuses of multiple embryos and select the one that has the best combination of probabilities for in vitro fertilization (IVF). Called preimplantion genetic diagnosis (PGD), this technique is practiced to help couples identify embryos that might have high risks of major genetic diseases such as Tay-Sachs disease. PGD remains expensive and inaccurate, but it will become a more attractive option as it improves.
In addition, ongoing improvements in computing power should help scientists better understand the complex interplay of genes. Determining the relationship of genetic makeup to traits like intelligence is a math problem that will probably never have an exact answer, but can be improved to provide more accurate probabilities.
CRISPR remains an experimental technique with many questions about the long-term safety of its editing process. Scientists and doctors fear that CRISPR may inadvertently impact non-target genes with unintended consequences. However, PGD carries no obvious downside because no modification of genetic matter occurs. Rather, the parents will be able to pick an embryo with a higher probability, based on the best research, of exhibiting desirable traits. This is less precise than CRISPR but could significantly increase chances of babies having desired traits.
This all raises complex ethical questions. To date, many national governments and states have banned gene editing of live human embryos. Governments have also banned genetic modifications of the human germline for imparting beneficial traits such as height or intelligence.
IVF combined with PGD, or well-tuned CRISPR interventions, could become a boutique treatment for wealthy folks seeking an edge for junior. This might further exacerbate already noted trends of rising assortative mating, in which people of like backgrounds and positions tend to marry each other. This concentrates wealth or other benefits further in a society, augmenting inequality.
Some argue that the government simply does not have the right to legislate how parents handle their children’s DNA. In this view, as long as these enhancements can be proven safe, then the government should not regulate them any more than it should regulate the ability of the wealthy to pay for expensive personal trainers to improve their physiques or expensive math tutors to help their children get into Ivy League schools.

Demand for designer babies?

Christmas Day marks the birthday of one of the most gifted human beings ever born. His brilliance was of a supernoval intensity, but he was, by all accounts, very far from pleasant company. I refer to Isaac Newton.
Would you like your next child to have the intelligence of a Newton? It may not be long before this is a consumer choice, according to an ambitious new company founded in America a few months ago. Genomic Prediction initially plans to offer people who use in-vitro fertilisation the chance to identify and avoid embryos that would be likely to develop diabetes, late-life osteoporosis, schizophrenia and dwarfism. The key is the application of smart software to gigantic databases of genomic information from the population at large so as to spot dangerous combinations of gene variants. The founders also talk of being able to predict intelligence from genes, at least to some degree.
It is of course already common practice to screen embryos for terrible diseases, but only those simply caused by single genes: cystic fibrosis, Huntington’s disease and so forth. The new idea is to extend this capability to disorders caused by the interaction of many genes, each of small effect: and that is most of them.
This is welcome and potentially ethical, but is it also, after many false starts, the beginning of the slippery slope to designer babies? No, it is not. If anything, the new knowledge will cause such a threat to dissolve.
It is true that intelligence is one of the most strongly heritable human traits, like height. In childhood, among people who get sufficient food and a reasonable education, genes account for about 40 per cent of the variation in IQ. Later in life this rises to more like 80 per cent. If this sounds puzzling, consider this friend of mine: left a bad school at 15, worked as a lorry driver for a big company, which spotted his intelligence and paid for him to attend a top university, where he got a first, rejoined the company and is now a global senior executive: his achievement at 45 better reflects his innate intelligence than his achievement at 15. As a child we don’t get to choose our environments, so clever kids often don’t get to read as many books or do as many mind-bending maths puzzles as they would like, while stupid children read more books and get more maths tutoring than they would if left to their own devices. By adulthood, we are choosing and modifying the life that suits us.
Hence it has always been possible selectively to breed for intelligence. Francis Galton in 1869 pointed out that just as it was easy to ‘obtain by careful selection a permanent breed of dogs or horses gifted with peculiar powers of running, or of doing anything else, so it would be quite practicable to produce a highly gifted race of men by judicious marriages during several consecutive generations’.
However, human beings proved surprisingly unwilling to do this, and most governments eventually gave up trying to coerce them to do it, often with horrific eugenic policies. Then along came artificial insemination and test-tube babies, and surely now we would see a rush to have bright babies, by using sperm banks of Nobel Prize winners? But we did not. People used these technologies to have their own children, not those of Newton-like sperm donors. It is curious
how wrong most experts were about where the demand for IVF would come from: mainly from infertile couples wanting their own children, not fertile people wanting other people’s.
Strange as it may seem to academics, not everybody thinks intelligence matters all that much. They would rather have good- looking or athletic or happy or kind children than super-bright ones. And healthy comes first for almost everybody, so if there is any risk of poor health as a result of selecting an embryo for intelligence, people will, and for all we know very wisely, avoid it.
That is the first reason we will not see designer-intelligence any time soon: there will be little demand, especially if the procedure carries risks. For 50 years we have fretted about designer babies every time there is a new reproductive technology: mitochondrial donation and cloning were the most recent reason for dusting off the old canard.
The second reason is that the genes involved are too numerous and too feeble to be of any practical use. For a long time there was a puzzling gap between what studies of twins and adopted children said about the heritability of intelligence (that it was high), and what genetic surveys found (next to nothing). The first genome-wide association studies — or GWAS — came up empty when looking for gene variants associated with high IQ.
That has changed, thanks to much bigger sample sizes, such as the UK Biobank, which has looked inside the genomes of half a million people of a certain age. Thus, a recent study of nearly 80,000 people, published in May, found 40 new gene variants associated with intelligence. Another study published in Nature of 1,238 extremely gifted intellectuals turned up more gene variants, including three in a gene called ADAM12.
But the more we find, the more ridiculous the idea of selecting for intelligence looks. Each variant seems to have a small effect, so you would need to fiddle with scores of genes to make a child bright, and fiddling with them might have unforeseen consequences for the health of the child. ADAM12, for example, is hard at work in every organ of the body.
As for the concern that genomic selection for intelligence, if it comes, will be available to the rich but not the poor — well, the same is true for good education. Opportunities to buy the best genes for your children will be dwarfed for decades to come by the ability of the rich to buy the best education for their children. If you must do something, do something about that instead: and preferably do so by making all education as good as the best, rather than as bad as the worst.
Finally, staring us in the face is a more obvious reason why intelligent designer babies will not happen soon and if they do, will not matter much. Individual intelligence is overrated. This is partly the well-worn argument that lots of other characteristics determine success, especially energy and diligence. We know people who are too bright to be decisive; or conversely achieve much in spite of their apparent disadvantages.
However, I mean something more than this. I mean that human achievements are always and everywhere collective. Every object and service you use is the product of different minds working together to invent or manage something that is way beyond the capacity of any individual mind. This is why central planning does not work. Ten million people eat lunch in London most days; how the heck they get what they want and when and where, given that a lot of them decide at the last minute, is baffling. Were there a London lunch commissioner to organise it, he would fail badly. Individual decisions integrated by price signals work, and work very well indeed.
And here is the key insight from evolution. Our brains grew big long, long before we achieved civilisation. We’ve had 1,200cc of intelligence for half a million years: even Neanderthals had huge brains. For 99 per cent of that time we were just another hard-pressed species, as bottle-nosed dolphins are today, and around 75,000 years ago we teeter-ed on the brink of extinction.
What changed was not some bright spark of a new gene being turned on, but that we began to exchange and specialise, to create collective intelligence, rather than rely on individual braininess. To put it another way, dozens of stupid people in a room who talk to each other will achieve far more than an equal number of clever people who don’t. The internet only underlines this point. Human intelligence is a distributed, collaborative phenomenon.

When will we have designer babies?

Within 20 to 40 years, sex will no longer be the preferred method of reproduction. Instead, half the population with decent health care will–no shitting you–have eggs grown from human skin and fertilized with sperm, then have the entire genome of about 100 embryo samples sequenced, peruse the highlights, and pick the best model to implant. At least that’s what Stanford law professor and bioethicist Hank Greely predicts in The End of Sex and the Future of Human Reproduction. But skin-grown humans aside, how long until we have “designer babies”?
Here’s where we are: a gene-editing tool called CRISPR/Cas9 has produced a variety of terrifying wonders over the past few years. In August, a group of scientists announced that they had successfully edited a human embryo to eradicate a heart condition. (The validity of their paper, published in the journal Nature, is now disputed, but Chinese scientists also claimed to have edited embryos in 2015, though with less success.) And “designer pets” are already within reach; mice have been turned green. Beagles have been doubledin muscle mass. Pigs have been shrunk to the size of cocker spaniels with “designer fur.” Woolly mammoths are being attempted.
Greely expects human selection to be less like the Build-a-Bear workshop which “designer pets” suggests, in which you start from scratch with a base animal and pick features from a menu, but rather in which prospective parents select from a pot of about 100 embryos made by two people for preferences like gender and health, and maybe tweak out the hereditary diseases with CRISPR/Cas9.
It’s debatable when and how CRISPR-edited embryos will be approved for implantation (Congress has currently banned the FDA from even considering it), and scientists are currently wrestling over putting a moratorium on its use on humans. CRISPR’s own co-founder Jennifer Doudna fears what eugenic nightmare her technology could bring; in 2015, she co-signed a letter calling for thorough investigation into potential risks “before any attempts at human engineering are sanctioned, if ever, for clinical testing.”

Designer babies fear

A landmark US study by scientists at Oregon Health and Science University in Portland has for the first time successfully edited out a genetic mutation that could cause heart disease, but the fearmongering over designer babies rages on. Where would research into cures for genetic diseases be without a good old debate around the scary future of eugenics?
For once, let’s not allow that rhetoric to take over the headlines, in the way that it did two years ago, when research into mitochondrial replacement therapy, so-called three-parent babies, made strides. This is a good and promising breakthrough, not something to fear.
It’s easy for those unaffected by genetic diseases to dismiss scientific progress as a step towards a future in which we start selecting a criterion of eye or hair colour from a design-your-own-baby catalogue. But for people like me, affected by an incurable genetic disease that caused me to go blind, scientific advancements into gene editing and mitochondrial replacement therapy offer nothing but hope. If there is any chance of potentially saving yourself or your baby from illness, don’t tell me you wouldn’t take the opportunity.
Don’t get me wrong, being blind has made me who I am today, and I’m grateful for that. I’ll continue fighting for equality and for the rights of disabled people, but my eyesight stops me from doing so many things that I could do otherwise. If we stop all progress into scientific research now because of the assumption that we are heading towards a society of designer babies, all that will happen is that some of us will continue to inherit often life-threatening diseases. If the only resistance to the continued research into curing genetic diseases is due to fears over a slide towards producing superhuman babies, I think people need to take a look at things from my perspective.

News articles - designer babies

Brief arguments against embryo screening

The religious argument, spearheaded by the Catholic Church but also strongly supported by many other religious groups. These argue very simply that life begins at conception. An embryo is a fertilized egg, and therefore it is a life; embryo screening results necessarily in the destruction of embryos, and is therefore taking a life.

A further religious objection is that the selection of what children should or should not be born should be up to God, and people should not attempt to take a role in it.

There are many other groups concerned with the ethics of embryo screening. One of the most serious arguments is the concern that allowing embryo screening to progress to what seems its natural end will result in a global eugenics program, where prospective parents will be able to “shop” for the preferred embryo. The advocates of this argument believe that this will lead to “designer babies”, children born to fit a certain profile. And just as only the wealthy can afford designer clothes, this would result in a dramatic difference between the rich and the poor, as such on-demand screening is likely to be incredibly expensive. The rich, therefore, will end up with made-to-order babies, while the poor will be left to the natural order. In this situation, wealth will perpetuate wealth by breeding for it, and the low-income will become second-class citizens to a master class of tailor-made children.

More here....


DNA - the promise and the price

DNA – The Promise & The Price provides an excellent resource for discussing the ethical implications of advancing genetic research, focusing on; gene therapy, stem cells and cloning. The documentary examines the frontiers of genetic science, revealing how researchers attempt to fulfil DNA’s potential to help cure and prevent disease. It also questions how some aspects of these novel technologies may have significant consequences for individuals and society. Bill Paterson: “Much is promised by genetic science, the manipulation of our genes. But can it deliver? And if it does are we ready to take responsibility for meddling with the very fabric of life itself: our DNA”.

Read more....

Human Genetic Engineering is a step too far

Below is from this source....

Human genetic engineering provokes strong reactions. Dr David King, director of Human Genetics Alert, recently warned: ‘In a world first, the Government has said it will allow scientists to begin developing the technology for genetic modification of human beings, although creation of actual GM babies will be prohibited for the moment. We believe the public will be horrified’ [Ref: Telegraph]. The government move comes in the context of an overhaul of legislation on assisted reproduction and embryology designed to take account of the latest scientific developments [Ref: Guardian]. The spectre of eugenics haunts the designer babies debate. As one journalist puts it, the idea of designer babies tends to prompt comparisons with the Nazis, the hatcheries in Aldous Huxley’s novel Brave New World and the biological underclass of the science fiction movie Gattaca [Ref: Times Online].

While there are real concerns about what the future might hold, the debate requires separating fact from science fiction. The argument of supporters of genetic engineering is that fears are often exaggerated. Rather than crossing a significant ethical threshold, they say we’ll benefit from a continued improvement in our ability to overcome disease and improve people’s lives. Deciding who is right first requires understanding what scientists are capable of doing today. Then future possibilities need to be assessed. Finally, we’ll be in a position to assess what poses the greatest danger: that we take a step too far or that we fail to take the necessary steps towards further scientific developments.